Imaging is crucial for stem cell therapy to monitor the location(s), numbers, and state of the implanted cells. Real-time imaging in particular can ensure proper cell delivery for best engraftment. However, established imaging tools such as MRI are limited by their temporal resolution for guidance during delivery. In contrast, photoacoustic imaging is ideally suited for real time, image-guided therapy. Here, we use silica-coated gold nanorods as photoacoustic contrast agents and deploy them to image and quantitate mesenchymal stem cells during implant into the muscle tissue of live mice. Silica-coated gold nanorods (SiGNRs) were created with standard methods and loaded into mesenchymal stem cells (MSCs) without transfection agents. There was no significant (p<0.05) toxicity or changes to cell proliferation after incubating MSCs with 0.05 nM SiGNRs for 3 hours. A panel of cytokines should only minor upregulation of inflammatory markers including interleukin-6. We used electron microscopy to illustrate vacuole-bound SiGNRs inside the cells. This cell staining increased photoacoustic signal 175% relative to MSCs without contrast agent-the silica coat itself increased signal 55% relative to uncoated GNRs. Using inductively coupled plasma spectroscopy, we found that there were 100,000 SiGNRs per MSC. This value was 5-fold higher than a MSC population stained with GNRs in the absence of silica coat. After labeling, cells were washed and injected into murine muscle tissue to simulate a muscular dystrophy patient. Mice (N=5) treated with these SiGNRlabeled MSCs exhibited no adverse events and implants up to 5 mm deep were easily visualized. The in vivo detection limit was 90,000 cells in a 100 uL bolus in mouse thigh muscle. Here, the B-mode signal is useful for orienting the treatment area and visualizing the delivery catheter while the photoacoustic mode offers cell-specific content. The photoacoustic signal was validated with histology a long-term fluorescent tracking dye after MSC transplant.
INTRODUCTION
Stem cell therapy (SCT) can be used to treat musculoskeletal disease including muscular dystrophy by regenerating myofibers. Many cell types under study have shown few adverse events and generation of muscle cells including satellite cells [1] and mesenchymal stem cells (MSCs) [2] . MSCs in particular have few problems and have been shown generate new and functional tissue. [2] [3] [4] [5] [6] However, the SCT is limited by poor cell viability. [7] [8] [9] [10] [11] [12] [13] [14] Imaging is important in SCT because cells can be delivered in the wrong location. [15, 16] Because magnetic resonance imaging was being used, the location and poor injection performance was not known until post-procedure imaging. One hope of the community is that better delivery-aided by better imaging tools-will improve the functional outcomes in SCT. Such imaging would report both the viability of the cells as well as their number and location. There are two main approaches to imaging in SCT: 1) use of reporter genes or 2) exogenous contrast. The fundamental limitation of reporter genes in positron emission tomography (PET) and optics is their alteration of the cells genome. While iron oxide nanoparticle can be used with MRI and have good performance features, this approach has temporal resolution of minutes, which limits their use as real-time imaging tools [15, [17] [18] [19] [20] .
Photoacoustic (PA) imaging is an alternative that generates pressure waves for imaging after excitation by a laser pulse. [21] [22] [23] [24] [25] [26] [27] [28] This approach may use oxy-and deoxy-hemoglobin [29] for contrast or add small molecules, [30] carbon nanotubes, [26, 31] or gold nanorods (GNRs) [32, 33] to amplify the signal. PA complements B-mode and is quantitative and non-invasive with short scan times. It does seem like a reasonable tool for imaging SCT because B-mode can image the catheter near delivery and PA can give cell-specific content.
Here we describe silica-coated GNRs (SiGNRs) for PA imaging in SCT. This paper describes the synthesis and characterization of SiGNRs and uses them to image MSCs in the musculature of living mice. The silica coat increases cell uptake and increases PA signal [33] [34] [35] . Important controls were toxicity analysis including MSC viability, proliferation, differentiation, and cytokine expression. After ex vivo quantitation, we implanted MSCs in living mice and measured detection limits.
METHODS AND MATERIALS
SiGNR Synthesis. The GNRs were prepared with surfactant templating and cleaned with centrifugation and dialysis. [36, 37] Silica was added by bringing the GNRs to 2.2 nM and adding with NaOH to adjust pH to ~ 10. Then, three 6 μL aliqutos of TEOS was added every 30 minutes while stirring.
Cell Culture. We used mesenchymal stem cells (MSCs) between passage 3 -12. The cells and media (including differentiation media) were from Lonza and cells were delivered at 5000 cells per cm 2 of space in flask. The SiGNRs were added ~ 4 days after plating and at an concentration of 0.0 to 0.14 nM and 3 -20 hours of incubation time. GNRs were similarly added to the cells. Cells loaded with silica-free GNRs were treated identically to the SiGNRs. After labeling cells are removed with trypsin, counted, and imaged or delivered to the animal subject. The MTT toxicity assay used 10,000 cells per plate, while the proliferation assays used 3000 cells per well to being with, each data point with 6 replicates.
MSCs with passage numbers below 6 were used for differentiation experiments. Cells were labeled with SiGNRs and grown according to standard protocol. Cell differenentation reagens were acauired from Lonza and included the adipogenic and osteogenic media. Cell staining used including Alzarin Red for osteocytes and Oil Red O for fat vacuoles. Cytokine expression was measured int eh cell culture media by a commercial operator (Rules Based Medicine; Austin, TX) [38] .
Inductively Coupled Plasma (ICP).
The ICP helped quantitate the number of SiGNRs per MSC. Cells were grown and labeled as described above and then detached from the culture dish and plated in aqua regia with sonication to dissolve the cell and GNRs or SiGNRs. The samples were then diluted and analyzed with an IRIS Advantage/1000 Radial ICAP Spectrometer system in duplicate. Standards were prepared similar and a standard curve was used to interpret the result.s PA Imaging. We used a LAZR commercial PA instrument (Visualsonics) and a 21 MHzcentered transducer. [39] Typical imaging conditions include 100% power, 50 dB gain, 21 MHz frequency, and 680 nm excitation. The laser output was monitored externally on the animal bed with a Gentec-eo power meter with sensor 1 cm from end of PA transducer as well as internal power sampling.
Animal Studies. All studies were approved by the Administrative Panel on Laboratory Animal Care. We used female nude mice (6-16 weeks old; n=3 at each point). After anesthetization, MSCs were injected in 1:1 saline:matrigel. To confirm the cell location with histology, we also used a cell tracking dye (SP-DiOC18(3)).
Data Analysis. The PA signal was interpreted using ROI analysis. We defined background as the PA-mode signal from the agar gel in the phantom. The in vivo detection limits were calculated by implanting sub-cutaneous material and imaging. Statistical treatment of secretome data used a two tailed t-test including 49 DOF. We assumed that the CV applied to both control and SiGNR groups. P-values were calculated using Excel.
RESULTS
Physical Characterization. We used TEM and spectroscopy to study the GNRs and SiGNRs. We found that the GNR peak was at 665 nm; the dimensions by TEM were 42.17 ± 5.11 nm by 14.90 ± 0.58 nm. These dimensions changed to 82.99 ± 3.86 by 64.20 ± 3.48 nm width after coating, and the peak shifted by 11 nm towards the red. [33] We found that the PA signal was four fold higher in SiGNRs than GNRs at 1.4 nM similar to previous reports. [33] We imaged the phantoms with the scanner and found that the PA signal and concentration of contrast agent had Cell Imaging. We next used the SiGNRs to label MSCs and showed that it can increase endocytosis. This was already shown in cells including. [40, 41] We used the MTT toxicity assays to find a concentration of SiGNR that gave the MSCs high PA signal and no toxicity. We found that SiGNRs at 0.07 nM (1.5 x 10 6 SiGNRs/MSC) was effective for this purpose. Incubation time was 3 hours. TEM imaging showed that after such treated, SiGNRs were clearly inside the MSCs and inside vesicles. When we studied how the PA signal was different in GNR and SiGNR tagged MSCs, we found that SiGNR cells had 7.6-fold more signal than GNR cells. The detection limit of SiGNR-labeled cells was 5000 MSCs. We used ICP to characterize the cells' gold concentration. We found that 102,000 ± 1,000 SiGNRs were present in each MSC. We also found that the gold concentration in GNR-tagged cells was 5-fold lower than the SiGNR samples. Figure 2. (A-D) . TEM images at increasing magnification illustrate that the SiGNRs have been phagocytosed into the MSCs. E) Backscatter mode and PA mode imaging of 1 nM SiGNRs, GNRs, and water as a blank control illustrates the signal enhancement due to silica coating.
Toxicity. In addition to metabolic screens, we also studied MSC proliferation to see if that proliferation changed because of SiGNR tagging. 3,000 labeld and unlabeled MSCs were plated and monitored with MTT, but no difference was seen in growth between the two cohorts. Both groups doubled in 3 days. The differentiation assays showed the MSCs could still direct towards both osteogenic and adipogenic lineages. Secretome analysis of SiGNR-labeled and unlabeled cells showed that 26 of the 31 proteins were detectable. Only interleukin-6 (IL-6) changed more than two-fold. Animal Imaging. The SiGNR cells were used in animals. Here, 80 µL of 0.7, 0.35 and 0.175 nM SiGNRs were injected sub-cutaneously and imaged with PA. We found the detection limit to be 0.05 nM. We injected SiGNR labeled cells using saline as the negative control. We also imaged decreasing numbers of cells with three mice at each point. We could image down to 100,000 cells and cells could be longitudinally monitored for up to 4 days before the difference in PA signal between treat3ed area and background lost statistical significance. The images were validated with histology. The treated area was excised, section and imaged with microscopy. We found that both muscle tissue and adjacent MSCs were clearly seen. Furthermore, the independent SP-DiOC18(3) cell tracking fluorophore was clearly visible. This is evidence that the increased PA signal came from SiGNR-labeled cells and not from trauma. 
DISCUSSION AND CONCLUSION
The SiGNRs are useful PA contrast agent for imaging of MSCs. The silica enhanced the photoacoustic signal of the GNRs [42] . It also increased GNRs phagocytosis. Such phagocytosis was best at 3 hours of incubation and a concentration of 0.07 nM. This gave high signal and no toxicity. We showed implantation guidance at 5 frames per second. The PA mode offered cellspecific content and the B-mode was useful for anatomic imaging of surrounding tissue. The detection limits of SiGNR was 0.03 nM and of 5,000 ex vivo/90,000 in vivo MSCs. Important, these cell numbers are well below what would be used clinically. [43] The ICP analysis indicated that there were 101,000 ± 1,000 SiGNRs/MSC, which is similar to previous reports of 50-150,000 nanorods per cell. [44] [45] [46] Toxicity analysis including proliferation assays and metabolic screens showed no toxicity to MSCs. Therew was also no unintended differentiation-this can sometime occur due to the presence of foreign bodies. [47, 48] The secretome data also suggest that the cells are relatively unchanged by the contrast agent. [49] Limitations to PA imaging include optical scatter and attenuation, reconstruction artefacts, and volume modifications of frequency and signal. Indeed, PA still is primarily a tool used in the first cm of tissue, and thus is suitable for musculo-skeletal applications. Use in deeper delivery sites would likely rely on optical catheters. One advantage of the high signal is that we could only label a small percentage of the cells.
CONCLUSION
The sensitivity of the technique was well below the number injected clinically. The PA data was validated with histology. Cell dosing conditions were found for little to no impact on metabolism, proliferation, pluripotency, or cell secretome. The 0.2 s temporal resolution of PA offers important instant information on the cell bolus.
